Anti-wrinkle treatments
Preventative anti-wrinkle treatment: what does the evidence show?
Starting anti-wrinkle treatment before lines are deeply established is sometimes described as preventative, but the long-term evidence is limited and treatment is not a guarantee against facial ageing.
What does ‘preventative’ mean?
The idea is that reducing selected repetitive facial movement may slow the development of lines that become visible at rest. This is different from preventing ageing. Skin still changes through ultraviolet exposure, genetics, smoking, hormonal change, loss of facial support and the passage of time, whether or not an injectable treatment is used.
Expression lines are also normal. A line appearing when you smile, frown or raise your eyebrows does not automatically need treatment. The relevant question is not whether somebody has reached a particular age, but whether there is a concern that matters to them and a proportionate, clinically appropriate way to address it.
The evidence is suggestive, not conclusive
A 2025 review found that early treatment may reduce muscle overactivity and could delay some dynamic lines becoming more established. However, the authors also identified important gaps: long-term trials are limited, treatment approaches vary and there is no agreed definition of the ideal starting age, dose or interval for prevention.
Earlier publications include small observational reports and a study comparing identical twins with very different treatment histories. These can generate useful hypotheses, but they cannot prove what would happen to an individual who starts young or show that repeated treatment is necessary. Genetics, sun exposure, skincare and other lifestyle differences can affect ageing over many years.
Starting younger is not automatically better
A 2023 evidence review reported a shortage of high-quality research in younger adults. It also found that prevention was a common reason for seeking treatment. Popularity, however, is not the same as clinical need, and there is no universal milestone at which everybody should begin.
If there is little movement-related concern, the likely visible benefit may be small. Repeated appointments also mean repeated cost and exposure to adverse effects. Daily sun protection, avoiding smoking and using a suitable skincare routine may be more relevant to some people’s long-term goals, while others may decide that no cosmetic treatment is needed.
A plan must preserve facial balance
Facial muscles work in groups. Softening movement in one region can change the balance with neighbouring muscles, including those that raise or lower the brows. A sensible plan therefore considers expression, muscle strength, eyelid and brow position, existing asymmetry and how much movement the person wishes to retain—not simply their age or a package of treatment areas.
Using more product, treating more regions or shortening intervals does not create stronger prevention evidence. The least intervention needed for an agreed goal may sometimes be appropriate; at other times the right recommendation is to wait. Regular review should ask whether the treatment still offers a worthwhile benefit rather than assuming it must continue indefinitely.
Downtime and adverse effects still apply
Temporary redness, tenderness, swelling, bruising or headache can occur. Less common effects include unwanted weakness in a nearby muscle, brow or eyelid heaviness, altered expression and increased asymmetry. Results vary, wear off over time and cannot guarantee that a line will never form.
Difficulty swallowing or breathing, slurred speech, widespread weakness, sudden visual symptoms or signs of a severe allergic reaction require urgent medical help. The UK Health Security Agency has specifically advised people with swallowing or breathing symptoms after a recent aesthetic procedure to seek prompt advice rather than wait for a routine review.
Consultation comes before the label
The General Medical Council requires a physical examination before an injectable cosmetic medicine is prescribed. Consultation should cover the person’s health, medicines, allergies, previous reactions, pregnancy or breastfeeding, neurological or muscular symptoms, skin infection, goals and alternatives. Suitability cannot be decided from a photograph or age alone.
A balanced discussion should separate what is known about temporary softening of movement-related lines from what remains uncertain about decades-long prevention. It should also allow time to reflect. Choosing to start later—or not at all—is a valid outcome when the expected benefit does not outweigh the limitations, cost or risks for that individual.